Effect of different intestinal conditions on the intermolecular interaction between insulin and cell-penetrating peptide penetratin and on its contribution to stimulation of permeation through intestinal epithelium
[Display omitted] Our recent studies have shown that the coadministration of cell-penetrating peptides (CPPs) is a potential strategy for oral delivery of peptide- and protein-based biopharmaceuticals. The intermolecular interaction between drug and CPP is an essential factor in the effective delive...
Gespeichert in:
Veröffentlicht in: | European journal of pharmaceutics and biopharmaceutics 2015-08, Vol.94, p.42-51 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 51 |
---|---|
container_issue | |
container_start_page | 42 |
container_title | European journal of pharmaceutics and biopharmaceutics |
container_volume | 94 |
creator | Kamei, Noriyasu Aoyama, Yukina Khafagy, El-Sayed Henmi, Mao Takeda-Morishita, Mariko |
description | [Display omitted]
Our recent studies have shown that the coadministration of cell-penetrating peptides (CPPs) is a potential strategy for oral delivery of peptide- and protein-based biopharmaceuticals. The intermolecular interaction between drug and CPP is an essential factor in the effective delivery of these drugs, but the characteristics of the interaction under the conditions of the intestinal lumen remain unknown. In this study, therefore, we examined the characteristics of binding of the amphipathic CPP penetratin to insulin and the efficiency of its enhancement of epithelial insulin transport at different pH and in simulated intestinal fluids (SIFs). The binding between insulin and penetratin was pH dependent and particularly decreased at pH 5.0. In addition, we clarified that the sodium taurocholate (NaTC) present in two types of SIF (fasted-state SIF [FaSSIF] and fed-state SIF [FeSSIF]) affected binding efficiency. However, the permeation of insulin through a Caco-2 cell monolayer was significantly facilitated by coincubation with l- or d-penetratin at various pH values. Moreover, the permeation-stimulating effect of l-penetratin was observed in FaSSIF containing NaTC and lecithin, but not in 3mM NaTC solution, suggesting that the presence of lecithin was the key factor in maintaining the ability of penetratin to enhance the intestinal absorption of biopharmaceuticals. This report describes the essential considerations for in vivo use and clinical application of a CPP-based oral delivery strategy. |
doi_str_mv | 10.1016/j.ejpb.2015.04.030 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1700104470</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0939641115002106</els_id><sourcerecordid>1700104470</sourcerecordid><originalsourceid>FETCH-LOGICAL-c422t-7d94bb1e23029b7a0c460abcb4888ef356672eb7922e20722744665d2e4ec83d3</originalsourceid><addsrcrecordid>eNp9Uctu1TAQtRCI3hZ-gAXykk3C2HFeEhtUlYdUiQ2sLduZ9PoqsYPtgPqj_R6cm_JYsbJn5sw5Z3QIecWgZMCat6cST4suObC6BFFCBU_IgXVtVVRCsKfkAH3VF41g7IJcxngCANHW3XNyweu-gaqCA3m4GUc0ifqRDjZ_A7pErUsYk3Vqosa7wSbrXaTe0XTE8zDMfkKzTirspTIbhGpMPxFd7sV1so4qN1CD01Qs6DAFlSnv6IJLsgPSv70zLq_bFDe9FKxez3zJ02xjzjrnMntcsjTuVToGv94d_zWLi80OJ7vOL8izUU0RXz6-V-Tbh5uv15-K2y8fP1-_vy2M4DwV7dALrRnyCnivWwVGNKC00aLrOhyrumlajrrtOUcOLeetEE1TDxwFmq4aqivyZuddgv--Zh9ytnE7WTn0a5SsBWAgRAsZyneoCT7GgKNcgp1VuJcM5JanPMktT7nlKUHInGdeev3Iv-oZhz8rvwPMgHc7APOVPywGGY1FZ3CwIecqB2__x_8LyZ64ww</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1700104470</pqid></control><display><type>article</type><title>Effect of different intestinal conditions on the intermolecular interaction between insulin and cell-penetrating peptide penetratin and on its contribution to stimulation of permeation through intestinal epithelium</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Kamei, Noriyasu ; Aoyama, Yukina ; Khafagy, El-Sayed ; Henmi, Mao ; Takeda-Morishita, Mariko</creator><creatorcontrib>Kamei, Noriyasu ; Aoyama, Yukina ; Khafagy, El-Sayed ; Henmi, Mao ; Takeda-Morishita, Mariko</creatorcontrib><description>[Display omitted]
Our recent studies have shown that the coadministration of cell-penetrating peptides (CPPs) is a potential strategy for oral delivery of peptide- and protein-based biopharmaceuticals. The intermolecular interaction between drug and CPP is an essential factor in the effective delivery of these drugs, but the characteristics of the interaction under the conditions of the intestinal lumen remain unknown. In this study, therefore, we examined the characteristics of binding of the amphipathic CPP penetratin to insulin and the efficiency of its enhancement of epithelial insulin transport at different pH and in simulated intestinal fluids (SIFs). The binding between insulin and penetratin was pH dependent and particularly decreased at pH 5.0. In addition, we clarified that the sodium taurocholate (NaTC) present in two types of SIF (fasted-state SIF [FaSSIF] and fed-state SIF [FeSSIF]) affected binding efficiency. However, the permeation of insulin through a Caco-2 cell monolayer was significantly facilitated by coincubation with l- or d-penetratin at various pH values. Moreover, the permeation-stimulating effect of l-penetratin was observed in FaSSIF containing NaTC and lecithin, but not in 3mM NaTC solution, suggesting that the presence of lecithin was the key factor in maintaining the ability of penetratin to enhance the intestinal absorption of biopharmaceuticals. This report describes the essential considerations for in vivo use and clinical application of a CPP-based oral delivery strategy.</description><identifier>ISSN: 0939-6411</identifier><identifier>EISSN: 1873-3441</identifier><identifier>DOI: 10.1016/j.ejpb.2015.04.030</identifier><identifier>PMID: 25960330</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Administration, Oral ; Caco-2 Cells ; Carrier Proteins - chemistry ; Carrier Proteins - metabolism ; Cell-penetrating peptide ; Chemistry, Pharmaceutical ; Drug Carriers ; Epithelial Cells - metabolism ; Humans ; Hydrogen-Ion Concentration ; Hypoglycemic Agents - administration & dosage ; Hypoglycemic Agents - chemistry ; Hypoglycemic Agents - metabolism ; Insulin ; Insulin - administration & dosage ; Insulin - chemistry ; Insulin - metabolism ; Intermolecular interaction ; Intestinal Absorption ; Intestinal Mucosa - metabolism ; Kinetics ; Lecithins - chemistry ; Models, Biological ; Oral absorption ; Penetratin ; Permeability ; Protein Binding ; Taurocholic Acid - chemistry ; Technology, Pharmaceutical - methods ; Tight Junctions - metabolism</subject><ispartof>European journal of pharmaceutics and biopharmaceutics, 2015-08, Vol.94, p.42-51</ispartof><rights>2015 Elsevier B.V.</rights><rights>Copyright © 2015 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c422t-7d94bb1e23029b7a0c460abcb4888ef356672eb7922e20722744665d2e4ec83d3</citedby><cites>FETCH-LOGICAL-c422t-7d94bb1e23029b7a0c460abcb4888ef356672eb7922e20722744665d2e4ec83d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ejpb.2015.04.030$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25960330$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kamei, Noriyasu</creatorcontrib><creatorcontrib>Aoyama, Yukina</creatorcontrib><creatorcontrib>Khafagy, El-Sayed</creatorcontrib><creatorcontrib>Henmi, Mao</creatorcontrib><creatorcontrib>Takeda-Morishita, Mariko</creatorcontrib><title>Effect of different intestinal conditions on the intermolecular interaction between insulin and cell-penetrating peptide penetratin and on its contribution to stimulation of permeation through intestinal epithelium</title><title>European journal of pharmaceutics and biopharmaceutics</title><addtitle>Eur J Pharm Biopharm</addtitle><description>[Display omitted]
Our recent studies have shown that the coadministration of cell-penetrating peptides (CPPs) is a potential strategy for oral delivery of peptide- and protein-based biopharmaceuticals. The intermolecular interaction between drug and CPP is an essential factor in the effective delivery of these drugs, but the characteristics of the interaction under the conditions of the intestinal lumen remain unknown. In this study, therefore, we examined the characteristics of binding of the amphipathic CPP penetratin to insulin and the efficiency of its enhancement of epithelial insulin transport at different pH and in simulated intestinal fluids (SIFs). The binding between insulin and penetratin was pH dependent and particularly decreased at pH 5.0. In addition, we clarified that the sodium taurocholate (NaTC) present in two types of SIF (fasted-state SIF [FaSSIF] and fed-state SIF [FeSSIF]) affected binding efficiency. However, the permeation of insulin through a Caco-2 cell monolayer was significantly facilitated by coincubation with l- or d-penetratin at various pH values. Moreover, the permeation-stimulating effect of l-penetratin was observed in FaSSIF containing NaTC and lecithin, but not in 3mM NaTC solution, suggesting that the presence of lecithin was the key factor in maintaining the ability of penetratin to enhance the intestinal absorption of biopharmaceuticals. This report describes the essential considerations for in vivo use and clinical application of a CPP-based oral delivery strategy.</description><subject>Administration, Oral</subject><subject>Caco-2 Cells</subject><subject>Carrier Proteins - chemistry</subject><subject>Carrier Proteins - metabolism</subject><subject>Cell-penetrating peptide</subject><subject>Chemistry, Pharmaceutical</subject><subject>Drug Carriers</subject><subject>Epithelial Cells - metabolism</subject><subject>Humans</subject><subject>Hydrogen-Ion Concentration</subject><subject>Hypoglycemic Agents - administration & dosage</subject><subject>Hypoglycemic Agents - chemistry</subject><subject>Hypoglycemic Agents - metabolism</subject><subject>Insulin</subject><subject>Insulin - administration & dosage</subject><subject>Insulin - chemistry</subject><subject>Insulin - metabolism</subject><subject>Intermolecular interaction</subject><subject>Intestinal Absorption</subject><subject>Intestinal Mucosa - metabolism</subject><subject>Kinetics</subject><subject>Lecithins - chemistry</subject><subject>Models, Biological</subject><subject>Oral absorption</subject><subject>Penetratin</subject><subject>Permeability</subject><subject>Protein Binding</subject><subject>Taurocholic Acid - chemistry</subject><subject>Technology, Pharmaceutical - methods</subject><subject>Tight Junctions - metabolism</subject><issn>0939-6411</issn><issn>1873-3441</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9Uctu1TAQtRCI3hZ-gAXykk3C2HFeEhtUlYdUiQ2sLduZ9PoqsYPtgPqj_R6cm_JYsbJn5sw5Z3QIecWgZMCat6cST4suObC6BFFCBU_IgXVtVVRCsKfkAH3VF41g7IJcxngCANHW3XNyweu-gaqCA3m4GUc0ifqRDjZ_A7pErUsYk3Vqosa7wSbrXaTe0XTE8zDMfkKzTirspTIbhGpMPxFd7sV1so4qN1CD01Qs6DAFlSnv6IJLsgPSv70zLq_bFDe9FKxez3zJ02xjzjrnMntcsjTuVToGv94d_zWLi80OJ7vOL8izUU0RXz6-V-Tbh5uv15-K2y8fP1-_vy2M4DwV7dALrRnyCnivWwVGNKC00aLrOhyrumlajrrtOUcOLeetEE1TDxwFmq4aqivyZuddgv--Zh9ytnE7WTn0a5SsBWAgRAsZyneoCT7GgKNcgp1VuJcM5JanPMktT7nlKUHInGdeev3Iv-oZhz8rvwPMgHc7APOVPywGGY1FZ3CwIecqB2__x_8LyZ64ww</recordid><startdate>20150801</startdate><enddate>20150801</enddate><creator>Kamei, Noriyasu</creator><creator>Aoyama, Yukina</creator><creator>Khafagy, El-Sayed</creator><creator>Henmi, Mao</creator><creator>Takeda-Morishita, Mariko</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20150801</creationdate><title>Effect of different intestinal conditions on the intermolecular interaction between insulin and cell-penetrating peptide penetratin and on its contribution to stimulation of permeation through intestinal epithelium</title><author>Kamei, Noriyasu ; Aoyama, Yukina ; Khafagy, El-Sayed ; Henmi, Mao ; Takeda-Morishita, Mariko</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c422t-7d94bb1e23029b7a0c460abcb4888ef356672eb7922e20722744665d2e4ec83d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Administration, Oral</topic><topic>Caco-2 Cells</topic><topic>Carrier Proteins - chemistry</topic><topic>Carrier Proteins - metabolism</topic><topic>Cell-penetrating peptide</topic><topic>Chemistry, Pharmaceutical</topic><topic>Drug Carriers</topic><topic>Epithelial Cells - metabolism</topic><topic>Humans</topic><topic>Hydrogen-Ion Concentration</topic><topic>Hypoglycemic Agents - administration & dosage</topic><topic>Hypoglycemic Agents - chemistry</topic><topic>Hypoglycemic Agents - metabolism</topic><topic>Insulin</topic><topic>Insulin - administration & dosage</topic><topic>Insulin - chemistry</topic><topic>Insulin - metabolism</topic><topic>Intermolecular interaction</topic><topic>Intestinal Absorption</topic><topic>Intestinal Mucosa - metabolism</topic><topic>Kinetics</topic><topic>Lecithins - chemistry</topic><topic>Models, Biological</topic><topic>Oral absorption</topic><topic>Penetratin</topic><topic>Permeability</topic><topic>Protein Binding</topic><topic>Taurocholic Acid - chemistry</topic><topic>Technology, Pharmaceutical - methods</topic><topic>Tight Junctions - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kamei, Noriyasu</creatorcontrib><creatorcontrib>Aoyama, Yukina</creatorcontrib><creatorcontrib>Khafagy, El-Sayed</creatorcontrib><creatorcontrib>Henmi, Mao</creatorcontrib><creatorcontrib>Takeda-Morishita, Mariko</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of pharmaceutics and biopharmaceutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kamei, Noriyasu</au><au>Aoyama, Yukina</au><au>Khafagy, El-Sayed</au><au>Henmi, Mao</au><au>Takeda-Morishita, Mariko</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of different intestinal conditions on the intermolecular interaction between insulin and cell-penetrating peptide penetratin and on its contribution to stimulation of permeation through intestinal epithelium</atitle><jtitle>European journal of pharmaceutics and biopharmaceutics</jtitle><addtitle>Eur J Pharm Biopharm</addtitle><date>2015-08-01</date><risdate>2015</risdate><volume>94</volume><spage>42</spage><epage>51</epage><pages>42-51</pages><issn>0939-6411</issn><eissn>1873-3441</eissn><abstract>[Display omitted]
Our recent studies have shown that the coadministration of cell-penetrating peptides (CPPs) is a potential strategy for oral delivery of peptide- and protein-based biopharmaceuticals. The intermolecular interaction between drug and CPP is an essential factor in the effective delivery of these drugs, but the characteristics of the interaction under the conditions of the intestinal lumen remain unknown. In this study, therefore, we examined the characteristics of binding of the amphipathic CPP penetratin to insulin and the efficiency of its enhancement of epithelial insulin transport at different pH and in simulated intestinal fluids (SIFs). The binding between insulin and penetratin was pH dependent and particularly decreased at pH 5.0. In addition, we clarified that the sodium taurocholate (NaTC) present in two types of SIF (fasted-state SIF [FaSSIF] and fed-state SIF [FeSSIF]) affected binding efficiency. However, the permeation of insulin through a Caco-2 cell monolayer was significantly facilitated by coincubation with l- or d-penetratin at various pH values. Moreover, the permeation-stimulating effect of l-penetratin was observed in FaSSIF containing NaTC and lecithin, but not in 3mM NaTC solution, suggesting that the presence of lecithin was the key factor in maintaining the ability of penetratin to enhance the intestinal absorption of biopharmaceuticals. This report describes the essential considerations for in vivo use and clinical application of a CPP-based oral delivery strategy.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>25960330</pmid><doi>10.1016/j.ejpb.2015.04.030</doi><tpages>10</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0939-6411 |
ispartof | European journal of pharmaceutics and biopharmaceutics, 2015-08, Vol.94, p.42-51 |
issn | 0939-6411 1873-3441 |
language | eng |
recordid | cdi_proquest_miscellaneous_1700104470 |
source | MEDLINE; Access via ScienceDirect (Elsevier) |
subjects | Administration, Oral Caco-2 Cells Carrier Proteins - chemistry Carrier Proteins - metabolism Cell-penetrating peptide Chemistry, Pharmaceutical Drug Carriers Epithelial Cells - metabolism Humans Hydrogen-Ion Concentration Hypoglycemic Agents - administration & dosage Hypoglycemic Agents - chemistry Hypoglycemic Agents - metabolism Insulin Insulin - administration & dosage Insulin - chemistry Insulin - metabolism Intermolecular interaction Intestinal Absorption Intestinal Mucosa - metabolism Kinetics Lecithins - chemistry Models, Biological Oral absorption Penetratin Permeability Protein Binding Taurocholic Acid - chemistry Technology, Pharmaceutical - methods Tight Junctions - metabolism |
title | Effect of different intestinal conditions on the intermolecular interaction between insulin and cell-penetrating peptide penetratin and on its contribution to stimulation of permeation through intestinal epithelium |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T02%3A57%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20different%20intestinal%20conditions%20on%20the%20intermolecular%20interaction%20between%20insulin%20and%20cell-penetrating%20peptide%20penetratin%20and%20on%20its%20contribution%20to%20stimulation%20of%20permeation%20through%20intestinal%20epithelium&rft.jtitle=European%20journal%20of%20pharmaceutics%20and%20biopharmaceutics&rft.au=Kamei,%20Noriyasu&rft.date=2015-08-01&rft.volume=94&rft.spage=42&rft.epage=51&rft.pages=42-51&rft.issn=0939-6411&rft.eissn=1873-3441&rft_id=info:doi/10.1016/j.ejpb.2015.04.030&rft_dat=%3Cproquest_cross%3E1700104470%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1700104470&rft_id=info:pmid/25960330&rft_els_id=S0939641115002106&rfr_iscdi=true |